Search Within

GDMT, Medicine

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (9)
  3. Editorial (1)
Groups
  1. Advanced Practice Providers (25)
  2. Department of Medicine (25)
  3. Gynecology Disease Management Team (25)
  4. Solid Tumor Oncology Division (24)
  5. Gynecologic Medicine Service (23)
  6. Nursing (22)

More Groups

People
  1. Elizabeth Halton (10)
  2. Renier Brentjens (10)
  3. Roisin O'Cearbhaill (8)
  4. Claudia Diamonte (7)
  5. Isabelle Riviere (6)
  6. Jae Park (6)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (2)
  6. 2019 (6)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Blood (3)
  3. Biology of Blood and Marrow Transplantation (2)
  4. Cancer Discovery (2)
  5. Gynecologic Oncology (2)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. Elsevier Inc. (5)
  3. American Association for Cancer Research (3)
  4. American Society of Hematology (3)
  5. Elsevier Science, Inc. (2)
  6. Nature Publishing Group (2)

More Publishers

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Retrospective analysis of BRCA-altered uterine sarcoma treated with poly(ADP-ribose) polymerase inhibitors
    Journal Article

    Rao, M.; Merrill, M.; Troxel, M.; Chiang, S.; Momeni-Boroujeni, A.; Hensley, M. L.; Schram, A. M.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Genotypically-selected pan cancer trial of camonsertib with palliative radiation in the treatment of metastatic tumors harboring an ataxia-telangiectasia mutated (ATM) mutation
    Meeting Abstract

    Lee, N. Y.; Michelle, R.; Huang, M.; Guo, R.; Ferreira, V.; Merril, M.; Sgroe, E.; Unger, T.; Koehler, M.; Setton, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Multiple isolated ovarian cancer recurrences in the cervix and vagina after supracervical hysterectomy: A case report
    Journal Article

    Nguyen, A. Q.; Ehmann, S.; Feinberg, J.; Tew, W. P.; Carthew, K.; Sonoda, Y.; Chi, D. S.
    Gynecologic Oncology Reports (2022)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; RivieĢ€re, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial
    Journal Article

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • A coordinated clinical center for young onset colorectal cancer
    Editorial

    Mendelsohn, R.; Palmaira, R. L.; Lumish, M.; Bacani, J.; Krishnan, A.; Weiss, J.; Semler, R.; Casson, A.; Arkema, A.; Carter, J.; more...
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Oncologic immunomodulatory agents in patients with cancer and COVID-19
    Journal Article

    Jee, J.; Stonestrom, A. J.; Devlin, S.; Nguyentran, T.; Wills, B.; Narendra, V.; Foote, M. B.; Lumish, M.; Vardhana, S. A.; Pastores, S. M.; more...
    Scientific Reports (2021)

    Fulltext@MSK | Save
  • A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
    Meeting Abstract

    O'Cearbhaill, R. E.; Park, J. H.; Halton, E. F.; Diamonte, C. R.; Mead, E.; Lakhman, Y.; Kane, P.; Riviere, I. C.; Brentjens, R. J.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • InSight Care pilot program: Redefining seeing a patient
    Journal Article

    Daly, B.; Kuperman, G.; Zervoudakis, A.; Baldwin Medsker, A.; Roy, A.; Ro, A. S.; Arenas, J.; Yanamandala, H. V.; Kottamasu, R.; Salvaggio, R.; more...
    JCO Oncology Practice (2020)

    Fulltext@MSK | Save